One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B: An observational study

Non-inferior antiviral efficacy and better renal safety have been reported in chronic hepatitis B patients with tenofovir alafenamide (TAF) treatment. The experience in real-world clinical practice is limited. We aimed to explore the efficacy after 1-year TAF treatment. A total of 148 patients (42 H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Cheng, Hsu, Chao-Wei, Chien, Rong-Nan, Tai, Dar-In
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276287/
https://www.ncbi.nlm.nih.gov/pubmed/35758355
http://dx.doi.org/10.1097/MD.0000000000029269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276287/
https://www.ncbi.nlm.nih.gov/pubmed/35758355
http://dx.doi.org/10.1097/MD.0000000000029269

Ejemplares similares